Visitors can learn about the company’s latest clinical studies, a novel targeted peptide ingredient, and the rest of the company’s nutraceutical portfolio.
Liposomal encapsulation is a nascent technology in the supplements space, and proving liposomes were created requires a battery of technical, expensive tests.
The formulation of TSI Group’s PeakATP has made it 46% more stable at 12 months and 59% more stable at 6 months in aseptic hot-fill processed beverages.